RARA and acute promyelocytic leukemia: A majority of PML-RARα binding sites (547 out of 556 binding sites) failed to overlap with the APL patient-specific differentially methylated regions, whereas only 3 PML-RARα binding sites, including RARβ2 promoter, were hypermethylated.